secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardian Pharmacy Services, Inc. (GRDN)
CIK:        0001802255
Form:       8-K
Filed at:   2025-03-26T23:59:59+00:00
Accession:  0001193125-25-064079
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardian Pharmacy Q4 revenue up 20% to $338.6M; FY net loss $71M on IPO charges
-------------------------------------------------------------------------------

- Q4 revenue $338.6M (+20% YoY); resident count 186,000 (+14% YoY).
- Q4 net income $11.8M (down $2.7M YoY); FY net loss $71.0M on $131.5M stock-comp from IPO/Reorg.
- Adjusted EBITDA Q4 $25.9M (+30% YoY); FY $90.8M (+19% YoY).
- No debt outstanding at year-end; $40M credit line available (expandable to $75M).
- FY2025 guidance: revenue $1.33B-$1.35B, Adj. EBITDA $97M-$101M; incl. ~$4M public co. costs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802255/000119312525064079/0001193125-25-064079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802255/000119312525064079/d843493d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-064079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer